NASDAQ
Cyteir Therapeutics, Inc. (CYT) has a current ratio of 28.07x as of Monday, May 25, 2026. This represents a 87.12% increase compared to its 12-month average of 15.00x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.